About Us
LEV VERKH, PhD
CHIEF REGULATORY AND CLINICAL DEVELOPMENT OFFICER.
Dr. Verkh's clinical and regulatory experience includes working for Pfizer, Baxter Bio Sciences, the Alliance Pharmaceutical Corporation and the Alpha Therapeutic Corporation. He has directed national and multi-national Phase I, II, III and IV clinical trials in such areas as cardiology, oncology, peripheral artery disease, hematology, blood disorders and imaging methods.
He is author or co-author of over 40 peer-reviewed publications. Through his efforts and the efforts of his teams, he has received FDA approval for several products that are currently on the market.
In addition to directing Stemedica's clinical trials within the United States, Dr. Verkh will be assisting foreign regulatory agencies to establish guidelines for stem cell technologies in medicine. He will also assist in organizing and supervising clinical trials outside the United States utilizing Stemedica technology.
Board of Directors...
- Roger J. Howe
PhD, Executive Chairman - Maynard A. Howe
PhD, Chief Executive Officer and Vice Chairman - Nikolai I. Tankovich
MD, PhD, FASLMS, President, Chief Medical Officer - Andrew Rothenberg
CPA, MBA, MS, Chief Financial Officer, Treasurer and Corporate Secretary - Alex Kharazi
MD, PhD, Chief Technology Officer - Lev Verkh
PhD, Chief Regulatory and Clinical Development Officer - Eugene Baranov
PhD, Vice President of Global Research - David M. McGuigan
Vice President of Marketing and Business Development - Tim Brown
MS, JD, Director, Intellectual Property - Alexei V. Lukashev
PhD, Director of Laser Stem Cell Division - Amy Sanson
MPIA, Senior Director, Asia Business Operations